Skip to content

taVNS for Upper Limb Rehabilitation

Optimization of Closed-loop Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) as a Neurorehabilitation Tool

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04129242
Enrollment
20
Registered
2019-10-16
Start date
2020-02-19
Completion date
2022-10-05
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke, Rehabilitation, Vagus Nerve Stimulation, Brain Stimulation, Occupational Therapy

Brief summary

This study explores the use of a new form of neuromodulation known as transcutaneous auricular vagus nerve stimulation (taVNS) which stimulates the ear. This stimulation will be delivered concurrently with upper limb motor rehabilitation training (3 days/week for 4 weeks) in chronic stroke patients. Patients will undergo a series of baseline assessments (including a brain scan), a 4-week course of motor rehabilitation, and post-assessments (including a second brain scan)

Detailed description

This study aims to refine and develop closed loop taVNS, establish activity with key biomarkers, and show initial feasibility in a small clinical trial. For paired taVNS to succeed as a clinical treatment, it is critical to develop and refine a closed-loop taVNS platform that delivers stimulation concurrently during specific movements of the motor rehabilitation training. Aim 1 develops this novel motion-gated closed-loop system that delivers taVNS in synchrony with specific upper limb motor activation (n=5) Aim 2 will combine the development of the closed-loop system with the investigator's mechanistic understanding to explore an open-label pilot trial (n=20) using closed-loop taVNS paired with task-specific training to determine the feasibility, safety, and potential effect size of this novel combination therapy.

Interventions

DEVICETranscutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training

A closed-loop taVNS system that delivers taVNS with upper-limb rehabilitation training in a chronic stroke population.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH
Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18-80 years old * Ischemic or hemorrhagic stroke that occurred at least 6 months prior * Completed conventional rehabilitation therapy at least one month prior * Unilateral limb weakness with Fugl Meyer-Upper Extremity Scale score less than or equal to 58 (out of 66)

Exclusion criteria

* Primary intracerebral hematoma, or subarachnoid hemorrhage * Bilateral upper extremity weakness * Other concomitant neurological disorders affecting upper extremity motor function * Documented history of dementia before or after stroke * Documented history of uncontrolled depression or psychiatric disorder either before or after stroke which could affect their ability to participate in the experiment * Uncontrolled hypertension despite treatment, specifically SBP (Systolic Blood Pressure) / DBP (Diastolic Blood Pressure) \>=180/100mmHg at baseline * Contraindicated for MRI scanning.

Design outcomes

Primary

MeasureTime frameDescription
Change in Fugl-Meyer Assessment of the Upper ExtremityMean change in FMA-UE score after 4 weeks of rehab, compared to baselineThe Fugl-Meyer Assessment of the Upper Extremity (FMA-UE) is a stroke rehabilitation assessment of arm/hand movement impairment. It is scored by assigning 30 items assessing voluntary arm/hand movements and 3 items assessing reflexes an ordinal rating (0=unable, 1=partial, 2=near normal), then summing the ratings to obtain a general statement of ability. Possible aggregate scores range from 0/66 to 66/66 points. Higher scores indicate greater levels of arm movement ability.

Countries

United States

Participant flow

Participants by arm

ArmCount
Paired taVNS + Task Specific Training
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training: A closed-loop taVNS system that delivers taVNS with upper-limb rehabilitation training in a chronic stroke population.
9
Unpaired taVNS + Task Specific Training
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training: A closed-loop taVNS system that delivers taVNS with upper-limb rehabilitation training in a chronic stroke population.
7
Total16

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyPhysician Decision11
Overall StudyProtocol Violation01

Baseline characteristics

CharacteristicPaired taVNS + Task Specific TrainingUnpaired taVNS + Task Specific TrainingTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
1 Participants2 Participants3 Participants
Age, Categorical
Between 18 and 65 years
8 Participants5 Participants13 Participants
Age, Continuous57.33 years
STANDARD_DEVIATION 8.28
58.71 years
STANDARD_DEVIATION 6.45
57.93 years
STANDARD_DEVIATION 7.34
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Black or African American
3 Participants3 Participants6 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
5 Participants4 Participants9 Participants
Sex: Female, Male
Female
5 Participants2 Participants7 Participants
Sex: Female, Male
Male
4 Participants5 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 10
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Change in Fugl-Meyer Assessment of the Upper Extremity

The Fugl-Meyer Assessment of the Upper Extremity (FMA-UE) is a stroke rehabilitation assessment of arm/hand movement impairment. It is scored by assigning 30 items assessing voluntary arm/hand movements and 3 items assessing reflexes an ordinal rating (0=unable, 1=partial, 2=near normal), then summing the ratings to obtain a general statement of ability. Possible aggregate scores range from 0/66 to 66/66 points. Higher scores indicate greater levels of arm movement ability.

Time frame: Mean change in FMA-UE score after 4 weeks of rehab, compared to baseline

Population: Adults with unilateral motor deficits post-stroke

ArmMeasureValue (MEAN)Dispersion
Paired taVNS + Task Specific TrainingChange in Fugl-Meyer Assessment of the Upper Extremity5 score on a scaleStandard Error 1.02
Unpaired taVNS + Task Specific TrainingChange in Fugl-Meyer Assessment of the Upper Extremity3.14 score on a scaleStandard Error 0.63

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026